Despite the US Court of Appeals for the Federal Circuit's ruling in Amgen v Sandoz, significant uncertainty concerning two key provisions of the BCPIA remains, as Pharmaceutical Practice Group Co-Chairs Steve Coyle and Leslie-Anne Maxwell describe in their article, "Amgen v Sandoz: The Biosimilars Saga Continues" published in Life Sciences IP Review, Autumn 2015 issue.

Steve Coyle, Leslie-Anne Maxwell, and Chad Dever wrote the article, "Ogres and Trolls," for Life Sciences IP Review magazine about inter-partes review and post-grant review and life sciences patents. 

Cantor Colburn is a Top 50 Best Performing Law Firm- Defendant and a Top 100 Most Active Law Firm-Defendant from the Patexia ANDA Intelligence Report 2024.

Managing Intellectual Property has recognized seven Cantor Colburn attorneys in its 2024 IP Stars guide, which brings together the world’s foremost law firm and corporate intellectual property experts, allowing the wider community to benefit from their insight, experience and perspectives.

Anne Maxwell, Partner and Chair of the Pharmaceutical Patent Practice Group, reports on the Amgen Inc. v. Sanofi case that has cemented enablement requirements drawn from the Wands Test and three recent biotech decisions in her article, "Federal Circuit cases provide enablement guidance following Supreme Court decision," appearing in the July/August 2023 issue of the Patent Lawyer Magazine. 

Cantor Colburn Co-Managing Partners Michael Cantor and Philmore Colburn and Partners Todd Garabedian, Anne Maxwell, David Fox, Leah Reimer, and Karl Vick are 2023 Patent Stars, from Managing Intellectual Property.

AUTM’s Annual Meeting is the largest gathering of technology transfer professionals. This year's meeting on February 19-21, 2023, in Austin is a chance to connect, and gain insights from world-class speakers and panels from more than 90 educational sessions. Cantor Colburn's team at the meeting is Anne Maxwell, Ph.D. Bryan Zerhusen, Ph.D., Charlie O'Brien and Nicholas Herrel, Ph.D. 

Cantor Colburn's article Will Biosimilar Applicants Opt Out of Patent Dance? Federal Court Ruling to Have Impact on Future Litigation Strategies," published by the Connecticut Law Tribune on April 20, 2015. Cantor Colburn has a strong IP Pharmaceutical Practice Group.

Members of Cantor Colburn's Pharmaceutical IP Services Practice Group co-authored an article on biosimilars entitled "BPCIA: How Long Does The Party Last And Do I Have To Dance?" that appeared in Law360 on March 24, 2015. The article is a discussion of Amgen Inc. v. Sandoz. Cantor Colburn has a strong IP Pharmaceutical Practice Group.

Cantor Colburn Partner Anne Maxwell co-authored the article "Purple Book Launches New Chapter in Generic Drugs" that was published in the October 23, 2014 Connecticut Law Tribune.

Leslie-Anne Maxwell, Ph.D., Partner and Pharmaceutical Group Co-Chair, wrote "Diagnostic Method Patents in Doubt" for the April 27, 2014 Connecticut Law Tribune regarding recent guidance from the U.S. Patent and Trademark Office in view of the U.S. Supreme Court decisions in Assoc. for Molecular Pathology v. Myriad Genetics and Mayo Collaborative Services v. Prometheus Laboratories, Inc. 

Cantor Colburn is sponsoring the 13th Annual Pharma IPR Conference in Mumbai, India, on March 5-7, 2024. Steve Coyle, Anne Maxwell, and Nick Geiger of the Pharmaceutical Practice will attend and Steve will present, Improperly Listed Orange Book Patents – Recent FTC Scrutiny and Strategies for ANDA Filers to Take Advantage. The Pharma IPR conference is India's largest global pharm IP conference, and Cantor Colburn has sponsored and attended for many years. 

Dr. Leslie-Anne Maxwell, Partner and Chair of Pharmaceutical Patent Practice Group at Cantor Colburn LLP will be the guest of the American Chemical Society, New Haven and Connecticut Valley Sections, presenting, "When Intellectual Property is Your Only Property – Strategies for New Companies," on February 27, 2024. Dennis Jakiela, Ph.D., Patent Agent with Cantor Colburn, chairs the 2024 ACS–New Haven Executive Board, and Cantor Colburn is a sponsor.

The 2023 Northeast Regional Meeting of the American Chemical Society (NERM 2023) will be organized by NESACS and will be hosted at Northeastern University in Boston. An all-star panel from Cantor Colburn LLP will discuss patent protection for innovative products or processes, which excludes others from making and selling the same products or using the same processes, can be critical to the profitability of tech companies. Cantor Colburn is proud to sponsor this meeting. 

The BIO International Convention 2023 is in Boston, June 5-8, 2023. Thousands of biotechnology and pharma leaders will come together for intensive networking to discover new opportunities and partnerships. Cantor Colburn partners Anne Maxwell, Ph.D. and Todd Garabedian, Ph.D. will attend. 

Anne Maxwell, Ph.D., Esq., Partner and Chair of the firm's Pharmaceutical Patent Practice, will attend the Women Leaders in Life Sciences Law Conference in Boston on July 27-28, 2022.

Leslie-Anne Maxwell, Ph.D., Esq. will attend The Yale Innovation Summit, on May 17-18, 2022 in New Haven, Connecticut. Anne is a Partner and chairs the firm's Pharmaceutical Patent Practice.

Anne Maxwell, Ph.D., Esq., Chair of Cantor Colburn's Pharmaceutical Patent Services Practice, will speak on at the Hatch-Waxman and BPCIA Passport to Proficiency Series, a virtual three-week program designed to provide new lawyers and executives for the life sciences industry with a solid foundation for understanding the essentials as well as the intricacies of Hatch-Waxman and BPCIA litigation and regulation. Dr. Maxwell speak on The Purple Book, focusing on generic pharmaceuticals. 

Cantor Colburn is pleased to sponsor the 9th Annual Pharma IPR Conference in Mumbai, India, on March 4-6, 2020. Steve Coyle and Anne Maxwell, Ph.D., Esq., co-chairs of the Pharmaceutical IP Services Practice Group, will attend, as will Nick Geiger.

Anne Maxwell, Ph.D., Esq. will attend the Women Leaders in Life Sciences Law conference in Boston on July 25-26, 2019. 

The BIO International Convention 2019 is in Philadelphia on June 3-6, 2019. More than 16,000 biotechnology and pharma leaders will come together for intensive networking to discover new opportunities and  partnerships among a wide spectrum of life science and application areas, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.  

Pharmaceutical Practice Group Co-Chair and partner Anne Maxwell, Ph.D. will attend the Managing IP Life Sciences Forum on September 12, 2018 in New York City. The conference brings together industry leaders, inhouse and outside counsel, and members of the judiciary to discuss the latest decisions and significant changes affecting the life sciences industry today. 

The 2018 BIO International Convention will take place on June 4-7, 2018, in Boston, Massachusetts. Cantor Colburn attorneys Todd Garabedian, Ph.D. and Anne Maxwell, Ph.D. will attend the 25th annual event. More than 16,500 life sciences professionals will flock to Boston for the convention.

Cantor Colburn is pleased to sponsor the 7th Annual Pharma IPR Conference in Mumbai, India, on March 7-9. 2018. Cantor Colburn's Pharmaceutical IP Services Practice Group handles litigation, patent prosecution, inter partes reviews and other Patent Office review proceedings, opinions, landscapes, competitive intelligence, transactional services, portfolio management, biosimilar and interchangeable biological drugs, and more. Steve Coyle, who leads the Pharmaceutical Litigation Group, will speak on "ANDA filling and litigation: strategies to respond."

The Summit on IP Due Diligence: Comprehensive and Practical Tips for Pharmaceutical, Biotechnology, and Medical Device Professionals will take place on November 2-3, 2017, in Philadelphia, Pennsylvania.

Cantor Colburn is proud to sponsor The 4th Annual Forum on Healthcare Innovation presented by The Jackson Laboratory for Genomic Medicine on October 25-26. 2017, at the Jackson Laboratory's Farmington, Connecticut headquarters. The Forum will focus on emerging science and technology that will change the future of healthcare, and innovations in healthcare.

Leslie-Anne Maxwell, Ph.D., Partner and Co-Chair of the Pharmaceutical IP Services Practice, spoke on "Pharma Patent Battles" at the Pharma and IP Legal Summit in Morristown, New Jersey on December 7th.

Cantor Colburn is proud to sponsor the Innovation Summit, presented by the Connecticut Technology Council.  

Partner Leslie-Anne Maxwell will present a session at the American Conference Institute's 6th Annual Summit on Biosimilars, a forum on the legal, regulatory, patent, and commercial realities of follow-on biologics, June 1-3, 2015, in New York City.  Maxwell, who holds a PhD in chemistry from Yale University as well as a legal degree, co-chairs the firm's Pharmaceutical Practice Group.

Cantor Colburn is proud to be a returning sponsor of the UConn Health White Coat Gala.

Cantor Colburn is the founding sponsor of the Connecticut Innovation Summit, the state's largest tech networking event, where innovative, emerging, and disruptive companies, premier service providers, and elite technology leaders meet and celebrate innovation. The event concludes with an Awards Ceremony, hosted by Co-Managing Partner Michael Cantor, which will recognize the next generation of high-growth companies in Connecticut.  

Cantor Colburn partners Anne Maxwell, Ph.D., Esq. and Christopher Boehm, Esq. will present "Understanding and Valuing Intellectual Property" to the Connecticut Chapter of the National Association of Certified Valuation Analysts on Thursday, October 23rd at the New Haven Realtors Association in North Haven, Connecticut.  

Cantor Colburn partner Anne Maxwell, Ph.D. will speak on Patent Invalidity Due to the On Sale Bar - Hamilton Beach Brands, Inc. v. Sunbeam Products, Inc. during the 30th annual Joint Patent Practice Continuing Legal Education on April 23, 2014 in New York, New York. 

The Keynote Speaker will be Hon. Alan D. Lourie of the U.S. Court of Appeals, Federal Circuit. Key government officials from the USPTO and FTC have been invited to join the program to discuss the latest developments in IP law. These include Drew Hirshfeld, USPTO Deputy Commissioner for Patent Examination Policy; Markus Meier, FTC Assistant Director; Janet Gongola, USPTO Patent Reform Coordinator and Associate Commissioner for Patent Examination Policy; Nathan Kelley, USPTO Solicitor and Deputy General Counsel for IP; and Hon. Thomas  Giannetti, USPTO Lead Administrative Patent Judge, Patent & Trial Board. 

Cantor Colburn partner Anne Maxwell, Ph.D., joins a panel discussion of the Association for Molecular Pathology v. Myriad Genetics decision and its impact on entrepreneurship In diagnostics and customized medicines at the Yale School of Medicine in New Haven on Tuesday, March 25, from 4-6 PM. This BioHaven seminar has convened a panel of experts from various sectors of the biotech and pharmaceutical industry to discuss the business implications of cases such as Myriad.

Cantor Colburn is sponsoring two intellectual property (IP) symposia in Mumbai and Ahmedabad, India on Strategies for Managing Pharma, Biotech & Chemical Patent Portfolios attended by research and development scientists and IP professionals from India, presented by the Institute of Intellectual Property Research & Development. Co-Managing Partner Michael Cantor and Pharmaceutical Litigation Practice Group Chair Steve Coyle will lead a team to make presentations on strategic generic pharmaceutical patent portfolio issues.

Cantor Colburn is sponsoring two intellectual property (IP) symposia in Mumbai and Ahmedabad, India on Strategies for Managing Pharma, Biotech & Chemical Patent Portfolios attended by research and development scientists and IP professionals from India, presented by the Institute of Intellectual Property Research & Development. Co-Managing Partner Michael Cantor and Pharmaceutical Litigation Practice Group Chair Steve Coyle will lead a team to make presentations on strategic generic pharmaceutical patent portfolio issues.

Cantor Colburn is a platinum sponsor of the Connecticut Innovation Summit, a day-long program for executives, entrepreneurs, rising technology leaders, and investors to come together to share ideas and promote innovation. The program includes mentor meetings, a funding fair, a sales pitch competition, a poster expo, and an awards ceremony.